Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint
Open Access
- 15 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 21 (1), 1-8
- https://doi.org/10.1186/s12891-020-03278-2
Abstract
Background Total hip arthroplasty (THA) has been highlighted as the best treatment option for ankylosing spondylitis (AS) patients with advanced hip involvement. The huge blood loss associated with THA is a common concern of postoperative complications. Disease activity is a specific reflection of systematic inflammation of AS. The purpose of this study was to determine the effect of disease activity on blood loss during THA in patients with AS. Methods Forty-nine patients with AS who underwent unilateral THAs were retrospectively studied. Ankylosing Spondylitis Disease Activity Score (ASDAS) was employed to evaluate the disease activity. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) formula was used to assess the surgical blood loss. The patients were divided into active group (ASDAS >= 1.3; n = 32) and stable groups (ASDAS< 1.3; n = 17) based on the ASDAS. Peri-operative laboratory values, plain radiographs, intra-operative data, transfusion volume, and use of hemostatic agents were recorded and statistically analyzed. Results The ASDAS, pre-operative C-reactive protein level, erythrocyte sedimentation rate, and fibrinogen concentration in the active group were higher than the stable group (all P < 0.05); however, the pre-operative hemoglobin concentration and albumin level were higher in the stable group (both P < 0.05). The total blood loss during THA in stable patients was 1415.31 mL and 2035.04 mL in active patients (P = 0.006). The difference between the two groups was shown to be consistent after excluding the gender difference (P = 0.030). A high transfusion rate existed in both groups (stable group, 76.47% with an average of 1.53 units; active group, 84.37% with an average of 2.31 units), but there was no significant difference between the two groups (both P > 0.05). Compensated blood loss, corresponding to transfusion, was noted significantly more in the active group compared to the stable group (P = 0.027). There was no significant difference with regard to functional recovery (P > 0.05). Conclusion Active AS patients are at high risk for increased blood loss during THA compared to stable patients. The underlying mechanism includes disorders of the coagulation and fibrinolytic systems, poor nutrition status, osteoporosis, imbalance of oxidative-antioxidative status and local inflammatory reaction. It is strongly recommended to perform THA in AS patients with stable disease.Keywords
Other Versions
This publication has 48 references indexed in Scilit:
- High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic reviewClinical Rheumatology, 2012
- Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessmentArthritis Research & Therapy, 2012
- Thrombin generation in ankylosing spondylitisClinical Rheumatology, 2010
- Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximabArthritis Care & Research, 2009
- Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockadeAnnals Of The Rheumatic Diseases, 2008
- Osteoporosis and vertebral fractures in ankylosing spondylitisCurrent Opinion in Rheumatology, 2007
- Disease and psychological status in ankylosing spondylitisRheumatology, 2006
- Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitisClinical Rheumatology, 2006
- Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe*Transfusion, 2003
- Guidelines for the clinical use of red cell transfusionsBritish Journal of Haematology, 2001